1. Scrip
  2. >>Leadership
  3. >>Executives On The Move

Appointments: New Leadership At ABPI, CMOs Appointed At Acceleron and Biophytis

 
• By Kevin Grogan

Pfizer's Erik Nordkamp has been named as the new president of the Association of the British Pharmaceutical Industry. Vant, Grail, Acceleron, Kite, Nimbus, Biophytis, Orchard Therapeutics, G1 Therapeutics, Almac Discovery, Athenex and Sunesis have also made key appointments.

Erik Nordkamp, managing director of Pfizer Inc. UK, has been confirmed as the new president of the Association of the British Pharmaceutical Industry, taking over the role vacated by the new CEO of Redx Pharma, Lisa Anson. Announcing the news, ABPI chief executive Mike Thompson said that Nordkamp was taking over "at arguably the most challenging period for the pharmaceutical industry in the UK as Britain continues to negotiate its withdrawal from the European Union, implement a modern industrial strategy and agree a deal on UK branded medicines policy for the next five years." 

Also, for the first time in its history, the ABPI has appointed a vice president, namely Haseeb Ahmad, Novartis...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Executives On The Move

Executives On The Move: Fable Therapeutics Gains CMO From AstraZeneca

Recent moves in the industry include changes at the top at 32 Biosciences, plus new CEOs at Idorsia, Courage Therapeutics and Oncolytics Biotech.

Executives On The Move: New CMOs At Instil Bio, Nkarta & Catalyst Pharma

Recent moves in the industry include changes at the top at iOnctura and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.

Executives On The Move: Three New CEOs And CFOs Among This Week’s Changes

Recent moves in the industry include changes at the top at Mitsubishi Tanabe Pharma and MC2 Therapeutics, plus MindMed acquires chief financial officer from Longboard Pharma.

Executives On The Move: Innate Pharma And Alloy Therapeutics Get New CEOs

Pascal Soriot, CEO of AstraZeneca, joins Agilent Technologies' board, plus Zealand Pharma acquires chief development officer from UCB Biopharma.

More from Leadership

Henlius CEO Details PD-L1 ADC’s Path To 1L Mono/Combo Therapy

 
• By Dexter Jie Yan

Henlius is investigating the optimum dose for its PD-L1-targeting antibody-drug conjugate HLX43 to support potential first-line use, its CEO explains to Scrip.

Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: breaking down big pharma’s executive pay; US vaccine panel upheaval; Merck’s RSV approval; MFN and Japan; and the future of Pfizer and Arvinas’s partnership.

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business

 
• By Anju Ghangurde

Sun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business.